These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37199165)

  • 1. Predictors of mortality for dermatomyositis patients positive with anti-melanoma differentiation-related gene 5 and optimal treatment.
    Liu L; Zhang Y; Shu X; Wang C; Guan W; Zhang X; Zhang L; Liu X; Wang L; Liu S; Li T
    Clin Exp Rheumatol; 2024 Feb; 42(2):246-252. PubMed ID: 37199165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ground-glass opacity score predicts the prognosis of anti-MDA5 positive dermatomyositis: a single-centre cohort study.
    Liu L; Zhang Y; Wang C; Guan W; Zhang X; Zhang L; He Y; Hu W; Liu S; Li T
    Orphanet J Rare Dis; 2023 Jul; 18(1):208. PubMed ID: 37480130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease.
    Li X; Liu Y; Cheng L; Huang Y; Yan S; Li H; Zhan H; Li Y
    J Clin Lab Anal; 2022 Nov; 36(11):e24726. PubMed ID: 36221983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China.
    You H; Wang L; Wang J; Lv C; Xu L; Yuan F; Li J; Wu M; Zhou S; Da Z; Qian J; Wei H; Yan W; Zhou L; Wang Y; Yin S; Zhou D; Wu J; Lu Y; Su D; Liu Z; Liu L; Ma L; Xu X; Zang Y; Liu H; Ren T; Wang F; Zhang M; Tan W
    Rheumatology (Oxford); 2023 Mar; 62(3):1216-1226. PubMed ID: 35961045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in patients with anti-MDA5-positive dermatomyositis: a cohort study of 251 cases.
    Cheng L; Xu L; Xu Y; Yuan F; Li J; Wu M; Da Z; Wei H; Zhou L; Yin S; Wu J; Lu Y; Su D; Liu Z; Liu L; Ma L; Xu X; Liu H; Ren T; Zang Y
    Clin Rheumatol; 2024 Jan; 43(1):339-347. PubMed ID: 37985533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients.
    Yang Q; Li T; Zhang X; Lyu K; Wu S; Chen Y; Liu S; Yu Z
    Orphanet J Rare Dis; 2021 Jan; 16(1):58. PubMed ID: 33516242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypouricemia as a novel predictor of mortality in anti-MDA5 positive dermatomyositis patients with ILD: A retrospective cohort study.
    Liu H; Chen B; Guo Y; Liu H; Ran J; Liu R; Yin G; Xie Q
    Respir Med; 2024 Feb; 222():107530. PubMed ID: 38228214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.
    Yamaguchi K; Yamaguchi A; Itai M; Kashiwagi C; Takehara K; Aoki S; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Takemura M; Hara K; Motegi SI; Muro Y; Nakasatomi M; Sakairi T; Hiromura K; Kurabayashi M; Maeno T
    Clin Rheumatol; 2019 Dec; 38(12):3443-3450. PubMed ID: 31420814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody-Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk.
    Lv C; You H; Xu L; Wang L; Yuan F; Li J; Wu M; Zhou S; Da Z; Qian J; Wei H; Yan W; Zhou L; Wang Y; Yin S; Zhou D; Wu J; Lu Y; Su D; Liu Z; Liu L; Ma L; Xu X; Zang Y; Liu H; Ren T; Wang F; Zhang M; Tan W
    J Rheumatol; 2023 Feb; 50(2):219-226. PubMed ID: 35705235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk Factors of Rapidly Progressive Interstitial Lung Disease in Patients With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis].
    Han YY; Jiang T; Zhang ZH; Li W; Jiang YD; Lu CC; Fei Y; Chen B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):422-425. PubMed ID: 36949709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.
    Huang K; Vinik O; Shojania K; Yeung J; Shupak R; Nimmo M; Avina-Zubieta JA
    Rheumatol Int; 2019 Nov; 39(11):1971-1981. PubMed ID: 31375890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5.
    Liu L; Zhang Y; Liu S; Wang C; Zhang L; Guan W; Zhang X; Li W; Shu X; Li T
    Rheumatology (Oxford); 2023 Sep; 62(9):3095-3100. PubMed ID: 36702462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study.
    Yamaguchi K; Nakajima T; Yamaguchi A; Itai M; Onuki Y; Shin Y; Uno S; Muto S; Kouno S; Yatomi M; Aoki-Saito H; Hara K; Endo Y; Motegi SI; Muro Y; Nakasatomi M; Sakairi T; Hiromura K; Katsumata N; Hirasawa H; Tsushima Y; Maeno T
    Clin Rheumatol; 2022 May; 41(5):1473-1481. PubMed ID: 35034225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.
    Jin Q; Fu L; Yang H; Chen X; Lin S; Huang Z; Gao B; Tian X; Jiang W; Shu X; Lu X; Wang G; Peng Q
    J Intern Med; 2023 Apr; 293(4):494-507. PubMed ID: 36682032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study.
    Ji Q; Pan W; Zhang D; Hou Y; Wang Z
    Front Immunol; 2023; 14():1237209. PubMed ID: 38098481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
    Wang LM; Yang QH; Zhang L; Liu SY; Zhang PP; Zhang X; Liu XJ; Han LS; Li TF
    Rheumatology (Oxford); 2022 Aug; 61(9):3704-3710. PubMed ID: 34940809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis.
    Kurasawa K; Arai S; Namiki Y; Tanaka A; Takamura Y; Owada T; Arima M; Maezawa R
    Rheumatology (Oxford); 2018 Dec; 57(12):2114-2119. PubMed ID: 30060040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease.
    Hata K; Kotani T; Matsuda S; Fujiki Y; Suzuka T; Kiboshi T; Wada Y; Shiba H; Shoda T; Kagitani M; Takeuchi T
    Int J Rheum Dis; 2024 Jan; 27(1):e14999. PubMed ID: 38063858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.
    Wu W; Guo L; Fu Y; Wang K; Zhang D; Xu W; Chen Z; Ye S
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):293-304. PubMed ID: 33405101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.